391 related articles for article (PubMed ID: 18345952)
1. Ulcerative proctitis: a review of pharmacotherapy and management.
Lakatos PL; Lakatos L
Expert Opin Pharmacother; 2008 Apr; 9(5):741-9. PubMed ID: 18345952
[TBL] [Abstract][Full Text] [Related]
2. Treatment of new-onset ulcerative colitis and ulcerative proctitis: a retrospective study.
Richter JM; Kushkuley S; Barrett JA; Oster G
Aliment Pharmacol Ther; 2012 Aug; 36(3):248-56. PubMed ID: 22690748
[TBL] [Abstract][Full Text] [Related]
3. A meta-analysis and overview of the literature on treatment options for left-sided ulcerative colitis and ulcerative proctitis.
Cohen RD; Woseth DM; Thisted RA; Hanauer SB
Am J Gastroenterol; 2000 May; 95(5):1263-76. PubMed ID: 10811338
[TBL] [Abstract][Full Text] [Related]
4. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis.
Marshall JK; Irvine EJ
Am J Gastroenterol; 2000 Jul; 95(7):1628-36. PubMed ID: 10925961
[TBL] [Abstract][Full Text] [Related]
5. Medical management of ulcerative proctitis, proctosigmoiditis, and left-sided colitis.
Bitton A
Semin Gastrointest Dis; 2001 Oct; 12(4):263-74. PubMed ID: 11726080
[TBL] [Abstract][Full Text] [Related]
6. Beclomethasone dipropionate (3 mg) enemas combined with oral 5-ASA (2.4 g) in the treatment of ulcerative colitis not responsive to oral 5-ASA alone.
D'Arienzo A; Manguso F; Castiglione GN; Vicinanza G; Scaglione G; Bennato R; Sanges M; Mazzacca G
Ital J Gastroenterol Hepatol; 1998 Jun; 30(3):254-7. PubMed ID: 9759590
[TBL] [Abstract][Full Text] [Related]
7. Clinical guidelines for the medical management of left-sided ulcerative colitis and ulcerative proctitis: summary statement.
Regueiro M; Loftus EV; Steinhart AH; Cohen RD;
Inflamm Bowel Dis; 2006 Oct; 12(10):972-8. PubMed ID: 17012968
[TBL] [Abstract][Full Text] [Related]
8. [Drug therapy for ulcerative colitis: salazosulfapyridine and 5-ASA].
Jo Y; Matsumoto T; Iida M
Nihon Rinsho; 2005 May; 63(5):820-4. PubMed ID: 15881176
[TBL] [Abstract][Full Text] [Related]
9. Mesalazine foam (Salofalk foam) in the treatment of active distal ulcerative colitis. A comparative trial vs Salofalk enema. The SAF-3 study group.
Ardizzone S; Doldo P; Ranzi T; Sturniolo GC; Giglio LA; Annese V; D'Arienzo A; Gaia E; Gullini S; Riegler G; Valentini M; Massa P; Del Piano M; Rossini F; Guidetti CS; Pera A; Greinwald R; Bianchi Porro G
Ital J Gastroenterol Hepatol; 1999 Nov; 31(8):677-84. PubMed ID: 10730559
[TBL] [Abstract][Full Text] [Related]
10. Ulcerative proctitis: an update on the pharmacotherapy and management.
Gecse KB; Lakatos PL
Expert Opin Pharmacother; 2014 Aug; 15(11):1565-73. PubMed ID: 24837209
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of clinical patterns in ulcerative colitis: a long-term follow-up.
Bresci G; Parisi G; Gambardella L; Banti S; Bertoni M; Rindi G; Capria A
Int J Clin Pharmacol Res; 1997; 17(1):17-22. PubMed ID: 9403349
[TBL] [Abstract][Full Text] [Related]
12. Review article: delivery and efficacy of topical 5-aminosalicylic acid (mesalazine) therapy in the treatment of ulcerative colitis.
Harris MS; Lichtenstein GR
Aliment Pharmacol Ther; 2011 May; 33(9):996-1009. PubMed ID: 21385194
[TBL] [Abstract][Full Text] [Related]
13. Combined therapy with 5-aminosalicylic acid tablets and enemas for maintaining remission in ulcerative colitis: a randomized double-blind study.
d'Albasio G; Pacini F; Camarri E; Messori A; Trallori G; Bonanomi AG; Bardazzi G; Milla M; Ferrero S; Biagini M; Quaranta S; Amorosi A
Am J Gastroenterol; 1997 Jul; 92(7):1143-7. PubMed ID: 9219787
[TBL] [Abstract][Full Text] [Related]
14. Management of distal ulcerative colitis: frequently asked questions analysis.
James SL; Irving PM; Gearry RB; Gibson PR
Intern Med J; 2008 Feb; 38(2):114-9. PubMed ID: 18290827
[TBL] [Abstract][Full Text] [Related]
15. Baseline Oral 5-ASA Use and Efficacy and Safety of Budesonide Foam in Patients with Ulcerative Proctitis and Ulcerative Proctosigmoiditis: Analysis of 2 Phase 3 Studies.
Bosworth BP; Sandborn WJ; Rubin DT; Harper JR
Inflamm Bowel Dis; 2016 Aug; 22(8):1881-6. PubMed ID: 27416045
[TBL] [Abstract][Full Text] [Related]
16. Topical agents for idiopathic distal colitis and proctitis.
Lawrance IC
J Gastroenterol Hepatol; 2011 Jan; 26(1):36-43. PubMed ID: 21175791
[TBL] [Abstract][Full Text] [Related]
17. Practicality of 5-aminosalicylic suppositories for long-term treatment of inactive distal ulcerative colitis.
Casellas F; Vaquero E; Armengol JR; Malagelada JR
Hepatogastroenterology; 1999; 46(28):2343-6. PubMed ID: 10521994
[TBL] [Abstract][Full Text] [Related]
18. Topical therapy is underused in patients with ulcerative colitis.
Seibold F; Fournier N; Beglinger C; Mottet C; Pittet V; Rogler G;
J Crohns Colitis; 2014 Jan; 8(1):56-63. PubMed ID: 23566922
[TBL] [Abstract][Full Text] [Related]
19. Pharmacologic therapy for inflammatory bowel disease.
Hirschfeld S; Clearfield HR
Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
[TBL] [Abstract][Full Text] [Related]
20. [Active and refractory ulcerative proctitis: an update].
Caselli M G; Pinedo M G; Zúñiga D A; Alvarez L M
Rev Med Chil; 2010 Jan; 138(1):109-16. PubMed ID: 20361160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
